Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Brain Stem Glioma
Interventions
RADIATION

Radiation

Subjects ≥ 3 years of age with a diffuse, intrinsic brain stem glioma will receive radiation.

DRUG

Atengenal

Subjects ≥ 3 years of age with a diffuse, intrinsic brain stem glioma will receive Atengenal in combination with Astugenal (Antineoplaston therapy) and radiation

DRUG

Astugenal

Subjects ≥ 3 years of age with a diffuse, intrinsic brain stem glioma will receive Astugenal in combination with Atengenal (Antineoplaston therapy) and radiation

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER